438 related articles for article (PubMed ID: 18159925)
1. Cell signaling and nuclear receptors: new opportunities for molecular pharmaceuticals in liver disease.
Staudinger JL; Lichti K
Mol Pharm; 2008; 5(1):17-34. PubMed ID: 18159925
[TBL] [Abstract][Full Text] [Related]
2. Liver-enriched nuclear receptors: therapeutic opportunities.
Staudinger JL
Mol Pharm; 2008; 5(1):1-2. PubMed ID: 18247475
[No Abstract] [Full Text] [Related]
3. Targeting nuclear bile acid receptors for liver disease.
Trauner M; Baghdasaryan A; Claudel T; Fickert P; Halilbasic E; Moustafa T; Zollner G
Dig Dis; 2011; 29(1):98-102. PubMed ID: 21691114
[TBL] [Abstract][Full Text] [Related]
4. FXR an emerging therapeutic target for the treatment of atherosclerosis.
Mencarelli A; Fiorucci S
J Cell Mol Med; 2010 Jan; 14(1-2):79-92. PubMed ID: 20041971
[TBL] [Abstract][Full Text] [Related]
5. Nuclear receptor variants in liver disease.
Zimmer V; Liebe R; Lammert F
Dig Dis; 2015; 33(3):415-9. PubMed ID: 26045277
[TBL] [Abstract][Full Text] [Related]
6. Nuclear receptors and nonalcoholic fatty liver disease.
Cave MC; Clair HB; Hardesty JE; Falkner KC; Feng W; Clark BJ; Sidey J; Shi H; Aqel BA; McClain CJ; Prough RA
Biochim Biophys Acta; 2016 Sep; 1859(9):1083-1099. PubMed ID: 26962021
[TBL] [Abstract][Full Text] [Related]
7. Non-coding RNA crosstalk with nuclear receptors in liver disease.
Wu J; Nagy LE; Liangpunsakul S; Wang L
Biochim Biophys Acta Mol Basis Dis; 2021 May; 1867(5):166083. PubMed ID: 33497819
[TBL] [Abstract][Full Text] [Related]
8. Nuclear Receptor Modulation for the Treatment of Nonalcoholic Fatty Liver Disease.
Fuchs CD; Traussnigg SA; Trauner M
Semin Liver Dis; 2016 Feb; 36(1):69-86. PubMed ID: 26870934
[TBL] [Abstract][Full Text] [Related]
9. Nuclear receptors as new perspective for the management of liver diseases.
Trauner M; Halilbasic E
Gastroenterology; 2011 Apr; 140(4):1120-1125.e1-12. PubMed ID: 21334334
[TBL] [Abstract][Full Text] [Related]
10. Nuclear Receptors Linking Metabolism, Inflammation, and Fibrosis in Nonalcoholic Fatty Liver Disease.
Puengel T; Liu H; Guillot A; Heymann F; Tacke F; Peiseler M
Int J Mol Sci; 2022 Feb; 23(5):. PubMed ID: 35269812
[TBL] [Abstract][Full Text] [Related]
11. Role of nuclear receptors in the modulation of insulin secretion in lipid-induced insulin resistance.
Sugden MC; Holness MJ
Biochem Soc Trans; 2008 Oct; 36(Pt 5):891-900. PubMed ID: 18793157
[TBL] [Abstract][Full Text] [Related]
12. Nuclear Receptors as Therapeutic Targets in Liver Disease: Are We There Yet?
Rudraiah S; Zhang X; Wang L
Annu Rev Pharmacol Toxicol; 2016; 56():605-626. PubMed ID: 26738480
[TBL] [Abstract][Full Text] [Related]
13. Essential role of nuclear receptors for the evaluation of the benefits of bioactive herbal extracts on liver function.
Wang F; Wu Y; Xie X; Sun J; Chen W
Biomed Pharmacother; 2018 Mar; 99():798-809. PubMed ID: 29710478
[TBL] [Abstract][Full Text] [Related]
14. Farnesoid X Receptor Deficiency Induces Hepatic Lipid and Glucose Metabolism Disorder via Regulation of Pyruvate Dehydrogenase Kinase 4.
Deng W; Fan W; Tang T; Wan H; Zhao S; Tan Y; Oware KA; Tan J; Li J; Qu S
Oxid Med Cell Longev; 2022; 2022():3589525. PubMed ID: 35251469
[TBL] [Abstract][Full Text] [Related]
15. A comprehensive data mining study shows that most nuclear receptors act as newly proposed homeostasis-associated molecular pattern receptors.
Wang L; Nanayakkara G; Yang Q; Tan H; Drummer C; Sun Y; Shao Y; Fu H; Cueto R; Shan H; Bottiglieri T; Li YF; Johnson C; Yang WY; Yang F; Xu Y; Xi H; Liu W; Yu J; Choi ET; Cheng X; Wang H; Yang X
J Hematol Oncol; 2017 Oct; 10(1):168. PubMed ID: 29065888
[TBL] [Abstract][Full Text] [Related]
16. Bile acids as regulators of hepatic lipid and glucose metabolism.
Trauner M; Claudel T; Fickert P; Moustafa T; Wagner M
Dig Dis; 2010; 28(1):220-4. PubMed ID: 20460915
[TBL] [Abstract][Full Text] [Related]
17. The PPARs and PXRs: nuclear xenobiotic receptors that define novel hormone signaling pathways.
Kliewer SA; Lehmann JM; Milburn MV; Willson TM
Recent Prog Horm Res; 1999; 54():345-67; discussion 367-8. PubMed ID: 10548883
[TBL] [Abstract][Full Text] [Related]
18. Orphan nuclear receptors, PXR and LXR: new ligands and therapeutic potential.
Gong H; Xie W
Expert Opin Ther Targets; 2004 Feb; 8(1):49-54. PubMed ID: 14996618
[TBL] [Abstract][Full Text] [Related]
19. Allosteric effects govern nuclear receptor action: DNA appears as a player.
Gronemeyer H; Bourguet W
Sci Signal; 2009 Jun; 2(73):pe34. PubMed ID: 19491383
[TBL] [Abstract][Full Text] [Related]
20. Molecular pathways involved in the transport of nuclear receptors from the nucleus to cytoplasm.
Tecalco-Cruz AC
J Steroid Biochem Mol Biol; 2018 Apr; 178():36-44. PubMed ID: 29107180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
